Media Coverage
BioAgilytix Makes Multi-Million-Dollar Investments in LC/MS Capabilities
Officials at BioAgilytix say the company has advanced its growth strategy with multi-million-dollar investments in liquid chromatography–mass spectrometry (LC/MS) capabilities, including new platforms and expanded lab space in Hamburg, Germany, and Durham, NC.
